Search for: "Perrigo Research "
Results 1 - 20
of 29
Sorted by Relevance
|
Sort by Date
12 Jun 2013, 1:53 pm
Lilly is engaged in the business of research, development, manufacture and sale of pharmaceutical products. [read post]
14 Sep 2009, 3:30 pm
The studies suggest that Boswellia has anti-inflammatory effects; there are at least 6 boswellic acids, including AKBA, which the research suggests is the most active. [read post]
1 Dec 2009, 9:45 am
Perrigo Company, Perrigo Israel Pharmaceuticals Ltd. [read post]
3 Jan 2013, 11:11 am
Perrigo acquired the remaining stake in Cobrek, a privately owned, venture-backed research and development company based in Chicago, for $45 million. 4. [read post]
23 Feb 2011, 3:35 am
(Patentology) China: Patentability of dosage regime invention in the form of Swiss-type claim under Chinese patent law (jiplp) US: Legislation to ban authorized generics during 180-day exclusivity period makes a comeback in Congress (FDA Law Blog) US: Market exclusivity, data exclusivity and S. 3921 (Holman’s Biotech IP Blog) US: President’s budget proposal increases funding for basic research but seeks to ‘trim’ data exclusivity period and pay-for-delay agreements… [read post]
20 Mar 2009, 6:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Reps Eshoo, Inslee and Barton introduce Pathway for Biosimilars Act (FDA Law Blog) (Patent Docs) (Patent Baristas) (Patent Baristas) (Law360) US: Reps Waxman, Pallone, Deal and Emerson introduce Promoting Innovation and Access to Life-Saving Medicine Act (Intellectual Property Watch) (IPKat) (Patent Docs) EU: Pharma submissions relating to… [read post]
15 Feb 2011, 5:26 pm
(FDA Law Blog) Diovan (Vasartan) – France: Novartis v Actavis – preliminary injunction for Valsartan confirmed (The SPC Blog) Diovan HTC (Valsartan) – Belgium: Antwerp Court of Appeal stops infringement of Valsartan/HCTZ SPC based on patent claiming Valsartan alone: Novartis v Teva (The SPC Blog) Lescol (Fluvastatin) – US: Novartis files patent infringement complaint against Mylan following Para IV challenge (Patent Docs) (GenericsWeb) Mucinex (Guaifenesin) – US: Watson… [read post]
21 Oct 2009, 6:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) – US: Shire announces… [read post]
24 Feb 2010, 2:11 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent… [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz… [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz… [read post]
24 Feb 2010, 2:11 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent… [read post]
13 Jul 2023, 9:16 pm
Opill, a daily “mini-pill” containing only one hormone, will be sold online and in stores in the first quarter of 2024 according to its manufacturer, Perrigo. [read post]
2 Nov 2011, 2:00 am
Research & Diagnostic Systems (Pharma Patents) US: Roundup Ready® Soybeans: Patent exhaustion in self-replicating biotechnologies (IP Osgoode) US: FDA continues efforts to expand power over intrastate commerce (FDA Law Blog) US: Defendants’ persistence in pursuing “baseless inequitable conduct claim” justified award of attorneys’ fees to plaintiff: Pfizer et. al v. [read post]
25 Jul 2022, 9:07 pm
On July 4, he met virtually and separately with the Global Group, Abbott, Gerber Products, Reckitt Danone, Bellamy’s Organic, Kendal Nutricare, and Perrigo. [read post]
13 Jul 2023, 1:10 pm
Perrigo Company PLC: Perrigo is a manufacturer of private-label and store-brand infant formulas. [read post]
12 Sep 2023, 5:00 am
The process was careful, deliberate, and based in science, involving a great deal of sophisticated research. [read post]
30 Jan 2012, 8:42 am
., Perrigo, Lauder, Queen of Tarts bloom.bg/AvVFBN Patent bubble finally bursts bit.ly/w1vmtO Louboutin Seeks to Overturn Ruling on Yves Saint Laurent’s Red-Soled Shoes bloom.bg/zaAAEW Antipiracy Case Sends Shivers Through Some Legitimate Storage Sites nyti.ms/zDfPy2 Megaupload’s Dotcom Seen as Flight Risk bloom.bg/xIHyfp Google to unify privacy policy across products bit.ly/z4gx16 Bartenders petition to protest proposed Mexican tequila regs bit.ly/y0WS9T Canada | Cupcake… [read post]
27 Jul 2011, 1:01 am
FDA is once again asked for guidance on drug delivery device patent Orange Book listing (this time by Forest Laboratories) (FDA Law Blog) US: Bio/Pharma legislation watch – Stem Cell Research Advancement Act of 2011, Confirming Genetic Diagnostic Test Activity Legislation, Medical Innovation Prize Fund Act, Seed Availability and Competition Act of 2011, Patent Continuing Disclosure Act (Patent Docs) US: District Court says “shall” means “must” in challenge to… [read post]
29 May 2020, 7:51 am
Janet Woodcock, director of the agency’s Center for Drug Evaluation and Research, said in the April 1, 2020 news release, titled “FDA Requests Removal of All Ranitidine Products (Zantac) from the Market. [read post]
